This is the authors' abstract. We don't add key points for this paper.
Background and Aims Preventive measures are effective against COVID-19 in kidney transplant recipients (KTR). We analysed whether sharing the antibody level after COVID-19 vaccination with these patients is associated with a change in adherence to preventive measures and if so, with the incidence of COVID-19. Method We included adult KTR who participated in the Long-term Efficacy and Safety of SARS-CoV-2 (LESS CoV-2) cohort study. Anti-RBD IgG levels were measured using ELISA (Sanquin, Amsterdam) one month after the third COVID-19 vaccination. Adherence to nine preventive measures was self-reported on a 5-point Likert scale, before and after the antibody level was shared. Based on their antibody level, patients were classified as high-responders (>300 BAU/mL), low-responders (50-300 BAU/mL), or non-responders (<50 BAU/mL) to COVID-19 vaccination. Information about incidence of COVID-19 was collected until 6 months after sharing the antibody level. For analysis, we calculated average adherence to all preventive measures with a range from 1 to 5. Multivariable logistic regression analysis was performed to assess an association between change of adherence and incidence of COVID-19. Results We included 1928 KTR, of whom 1058 high-responders, 548 low-responders, and 322 non-responders. After sharing antibody levels, adherence to preventive measures decreased in the total population (before: 4.11 [3.60-4.44] versus after: 4.00 [3.23-4.44], p < 0.001). This change of adherence was more pronounced in high-responders than in low- and non-responders (0.21 ± 0.68, 0.11 ± 0.56, and 0.14 ± 0.56 respectively, p = 0.02). During follow-up, COVID-19 was diagnosed in 627 of 1928 KTR (33%). In high-responders, the incidence of COVID-19 was higher in patients with decreased adherence compared to patients with increased adherence (decreased: 196 of 617 [32%] versus increased: 114 of 441 [26%], p = 0.04). The change of adherence in high-responders was associated with COVID-19 (OR 0.73 per unit increase [0.60-0.89], p = 0.002), but not after correction for confounding (aOR: 0.86 [0.68-1.07], p = 0.2). Conclusion Sharing anti-SARS-CoV-2 antibody levels with KTR was associated with a decrease in adherence to preventive measures, especially in KTR with a high antibody response to vaccination. In these high-responders, the risk of COVID-19 increased with decreasing adherence to preventive measures. This was not observed in low- or non-responders. Sharing antibody levels with KTR influences adherence to preventive measures and risk of COVID-19, and therefore requires careful communication.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bouwmans et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: